These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 17073452)
1. Phospholamban and its phosphorylated form interact differently with lipid bilayers: a 31P, 2H, and 13C solid-state NMR spectroscopic study. Abu-Baker S; Lorigan GA Biochemistry; 2006 Nov; 45(44):13312-22. PubMed ID: 17073452 [TBL] [Abstract][Full Text] [Related]
2. Side chain and backbone dynamics of phospholamban in phospholipid bilayers utilizing 2H and 15N solid-state NMR spectroscopy. Abu-Baker S; Lu JX; Chu S; Brinn CC; Makaroff CA; Lorigan GA Biochemistry; 2007 Oct; 46(42):11695-706. PubMed ID: 17910421 [TBL] [Abstract][Full Text] [Related]
3. Investigating structural changes in the lipid bilayer upon insertion of the transmembrane domain of the membrane-bound protein phospholamban utilizing 31P and 2H solid-state NMR spectroscopy. Dave PC; Tiburu EK; Damodaran K; Lorigan GA Biophys J; 2004 Mar; 86(3):1564-73. PubMed ID: 14990483 [TBL] [Abstract][Full Text] [Related]
4. The structural properties of the transmembrane segment of the integral membrane protein phospholamban utilizing (13)C CPMAS, (2)H, and REDOR solid-state NMR spectroscopy. Karp ES; Tiburu EK; Abu-Baker S; Lorigan GA Biochim Biophys Acta; 2006 Jun; 1758(6):772-80. PubMed ID: 16839519 [TBL] [Abstract][Full Text] [Related]
5. The structural topology of wild-type phospholamban in oriented lipid bilayers using 15N solid-state NMR spectroscopy. Abu-Baker S; Lu JX; Chu S; Shetty KK; Gor'kov PL; Lorigan GA Protein Sci; 2007 Nov; 16(11):2345-9. PubMed ID: 17905829 [TBL] [Abstract][Full Text] [Related]
6. Probing the interaction of Arg9Cys mutated phospholamban with phospholipid bilayers by solid-state NMR spectroscopy. Yu X; Lorigan GA Biochim Biophys Acta; 2013 Nov; 1828(11):2444-9. PubMed ID: 23850636 [TBL] [Abstract][Full Text] [Related]
7. (15)N Solid-state NMR spectroscopic studies on phospholamban at its phosphorylated form at ser-16 in aligned phospholipid bilayers. Chu S; Abu-Baker S; Lu J; Lorigan GA Biochim Biophys Acta; 2010 Mar; 1798(3):312-7. PubMed ID: 20044975 [TBL] [Abstract][Full Text] [Related]
8. Probing the oligomeric state of phospholamban variants in phospholipid bilayers from solid-state NMR measurements of rotational diffusion rates. Hughes E; Clayton JC; Middleton DA Biochemistry; 2005 Mar; 44(10):4055-66. PubMed ID: 15751982 [TBL] [Abstract][Full Text] [Related]
9. Secondary structure, backbone dynamics, and structural topology of phospholamban and its phosphorylated and Arg9Cys-mutated forms in phospholipid bilayers utilizing 13C and 15N solid-state NMR spectroscopy. Yu X; Lorigan GA J Phys Chem B; 2014 Feb; 118(8):2124-33. PubMed ID: 24511878 [TBL] [Abstract][Full Text] [Related]
10. Investigating the dynamic properties of the transmembrane segment of phospholamban incorporated into phospholipid bilayers utilizing 2H and 15N solid-state NMR spectroscopy. Tiburu EK; Karp ES; Dave PC; Damodaran K; Lorigan GA Biochemistry; 2004 Nov; 43(44):13899-909. PubMed ID: 15518538 [TBL] [Abstract][Full Text] [Related]
11. Solid-state (2)H and (15)N NMR studies of side-chain and backbone dynamics of phospholamban in lipid bilayers: investigation of the N27A mutation. Chu S; Coey AT; Lorigan GA Biochim Biophys Acta; 2010 Feb; 1798(2):210-5. PubMed ID: 19840770 [TBL] [Abstract][Full Text] [Related]
12. Investigating the interaction of saposin C with POPS and POPC phospholipids: a solid-state NMR spectroscopic study. Abu-Baker S; Qi X; Lorigan GA Biophys J; 2007 Nov; 93(10):3480-90. PubMed ID: 17704143 [TBL] [Abstract][Full Text] [Related]
13. Atomistic Structure and Dynamics of the Ca Aguayo-Ortiz R; Espinoza-Fonseca LM Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019581 [TBL] [Abstract][Full Text] [Related]
14. 31P and 2H relaxation studies of helix VII and the cytoplasmic helix of the human cannabinoid receptors utilizing solid-state NMR techniques. Tiburu EK; Karp ES; Birrane G; Struppe JO; Chu S; Lorigan GA; Avraham S; Avraham HK Biochemistry; 2006 Jun; 45(23):7356-65. PubMed ID: 16752925 [TBL] [Abstract][Full Text] [Related]
15. Solid-state nuclear magnetic resonance relaxation studies of the interaction mechanism of antimicrobial peptides with phospholipid bilayer membranes. Lu JX; Damodaran K; Blazyk J; Lorigan GA Biochemistry; 2005 Aug; 44(30):10208-17. PubMed ID: 16042398 [TBL] [Abstract][Full Text] [Related]
16. The cytoplasmic domains of phospholamban and phospholemman associate with phospholipid membrane surfaces. Clayton JC; Hughes E; Middleton DA Biochemistry; 2005 Dec; 44(51):17016-26. PubMed ID: 16363815 [TBL] [Abstract][Full Text] [Related]
17. Molecular order and dynamics of phosphatidylcholine bilayer membranes in the presence of cholesterol, ergosterol and lanosterol: a comparative study using 2H-, 13C- and 31P-NMR spectroscopy. Urbina JA; Pekerar S; Le HB; Patterson J; Montez B; Oldfield E Biochim Biophys Acta; 1995 Sep; 1238(2):163-76. PubMed ID: 7548131 [TBL] [Abstract][Full Text] [Related]
18. Investigating the interaction between peptides of the amphipathic helix of Hcf106 and the phospholipid bilayer by solid-state NMR spectroscopy. Zhang L; Liu L; Maltsev S; Lorigan GA; Dabney-Smith C Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):413-8. PubMed ID: 24144541 [TBL] [Abstract][Full Text] [Related]
19. Solid-state NMR measurements of the kinetics of the interaction between phospholamban and Ca2+-ATPase in lipid bilayers. Hughes E; Middleton DA Mol Membr Biol; 2005; 22(4):353-61. PubMed ID: 16154906 [TBL] [Abstract][Full Text] [Related]
20. Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers. Cornea RL; Jones LR; Autry JM; Thomas DD Biochemistry; 1997 Mar; 36(10):2960-7. PubMed ID: 9062126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]